Continuous Cuffless Blood Pressure Estimation Using PPG From Methods to Clinical Translation
Organizations: Department of Electrical and Computer Engineering, The University of Texas at Dallas, Richardson, USA
Abstract
Continuous blood pressure (BP) monitoring could improve hypertension management by capturing changes that intermittent cuff measurements miss. Photoplethysmography (PPG) is widely explored for cuffless BP estimation because optical sensors are inexpensive, wearable, and already present in many consumer and clinical devices. PPG, however, does not measure arterial pressure: BP is inferred from waveform characteristics or pulse timing, which also depend on vascular tone, arterial stiffness, sensor contact, motion, and individual physiology. This survey reviews PPG-based cuffless BP estimation along the full measurement chain, covering physiological mechanisms, waveform features, pulse arrival time (PAT), pulse transit time (PTT), machine-learning methods, datasets, calibration, validation, deployment, bias, and clinical translation. Studies are assessed by the strength of evidence they provide rather than by reported error alone, with particular attention to subject and temporal leakage, dataset imbalance, calibration dependence and drift, motion artifacts, and the gap between benchmark accuracy and reliable real-world measurement. The review finds that progress depends on more than better prediction algorithms. Future work should prioritize physiologically informed models, diverse longitudinal datasets, transparent reporting of calibration requirements and failure rates, stronger evaluation protocols, and studies that demonstrate practical value in clinical care.
Figures & tables
| Feature | Intended meaning | Major risk |
|---|---|---|
| Systolic amplitude | Pulse volume | Contact/optical variation |
| Upstroke slope | Ejection and stiffness | Motion and filtering effects |
| Rise time | Transit-related behavior | Landmark instability |
| Pulse width | Waveform duration | Heart-rate dependence |
| Dicrotic notch | Reflection/valve timing | Often absent in wrist PPG |
| Derivative peaks | Morphological detail | Noise amplification |
| Approach | Typical input | Main strength | Main limitation | Calibration dependence |
| Feature-based regression | Handcrafted PPG or ECG–PPG features | Interpretable, low computational cost | Bounded by feature quality; sensitive to artifacts | Sensitive to calibration choices |
| Pulse timing (PAT/PTT) | ECG and one or two PPG sites | Physiological link to arterial stiffness | PEP, vascular tone, and aging confound timing | Generally requires calibration |
| Deep learning | Raw or transformed waveforms | Captures nonlinear waveform patterns | Overfitting; limited interpretability | Often reported as calibration-free; vulnerable to leakage |
| Waveform reconstruction | PPG mapped to the arterial waveform | Physiologically plausible output shape | Errors harder to express in mmHg | Depends on evaluation design |
| Multimodal fusion | PPG with ECG, accelerometry, PCG, or demographics | Potentially more robust | Device complexity and user burden | Varies by design |
| Personalized or adaptive | Population model plus user data | Reduces inter-subject variability | Requires reference readings | Explicitly calibration-dependent |
| Evidence type | Typical contribution | What it supports | Main limitation |
|---|---|---|---|
| PPG physiology | Explains optical waveform morphology and fiducial features | Supports interpretation of PPG-derived features | Does not establish BP accuracy |
| PTT/PAT theory | Links pulse timing to vascular stiffness and pulse propagation | Supports timing-based BP estimation mechanisms | Sensitive to PEP, tone, stiffness, and calibration |
| Classical ML | Uses engineered waveform and timing features for regression | Demonstrates algorithmic feasibility | Strongly affected by dataset split and feature quality |
| Deep learning | Learns waveform representations from raw or transformed signals | Captures nonlinear patterns | Risk of overfitting and limited interpretability |
| Datasets and validation | Provides waveform resources and evaluation standards | Supports benchmarking and clinical translation discussion | Dataset realism and cuffless validation remain unresolved |
| Study | Signal / Model | Dataset (subjects) | Subject-independent? | Reported performance | Evidence-ladder tier |
| Kachuee et al., 2017 [ 36 ] | PPG + ECG (PAT); AdaBoost | UCI/MIMIC-II; 942 subjects | Not reported | SBP 11.17 mmHg; DBP 5.35 mmHg (corroborated in [ 58 , 46 ] ) | Algorithmic feasibility |
| Slapňičar et al., 2019 [ 41 ] | PPG + derivatives; spectro-temporal CNN | MIMIC-III; 510 subjects | Yes; leave-one-subject-out | SBP 9.43 mmHg; DBP 6.88 mmHg | Validated measurement performance (single institution) |
| Ibtehaz et al., 2022 [ 46 ] | PPG only; U-Net waveform reconstruction (PPG2ABP) | UCI/MIMIC-II; 942 subjects (same source pool as Kachuee et al.) | No; random-window split permits subject overlap [ 59 ] | SBP mmHg; DBP mmHg | Algorithmic feasibility (leakage confirmed) |
| Pan et al., 2024 [ 47 ] | PPG only; waveform reconstruction | VitalDB (extended) | Not reported | SBP mmHg; DBP mmHg | Algorithmic feasibility |
| Mohammadi et al., 2025 [ 48 ] | PPG only; hybrid CNN–BiLSTM with attention | Not fully disclosed | Not reported; 5-fold cross-validation | SBP 1.88 mmHg; DBP 1.34 mmHg | Algorithmic feasibility |
| Zhang et al., 2026 [ 49 ] | PPG only; CWT + CNN | UCI Open BP Database; external validation on 26 participants | Partial; independent participant group used for external validation | Source dataset: SBP mmHg; DBP mmHg. External validation: (SBP); (DBP) | Algorithmic feasibility with limited external validation |
| Requirement | What should be reported | Why it matters | Risk if missing |
|---|---|---|---|
| Mean error and SD | Bias and spread of error in mmHg | Aligns with BP validation conventions | Average performance may be misleading |
| MAE and RMSE | Absolute and squared-error summaries | Quantifies prediction error magnitude | Large individual errors may be hidden |
| Bland–Altman analysis | Agreement and limits of agreement across BP range | Reveals systematic bias and outliers | Unsafe errors may be missed |
| BP-range stratification | Error in low, normal, elevated, and high BP ranges | Tests clinically important ranges | Hypertension performance may be weak |
| Subject-independent split | No subject overlap between training and testing | Prevents identity leakage | Inflated benchmark accuracy |
| Temporal separation | Prevents adjacent windows from crossing train/test sets | Avoids correlation leakage | Unrealistically low error |
| Dataset | Typical setting | Subjects | Sampling rate | Useful signals | Main limitation |
| MIMIC-III Waveform Database | ICU | 30,000 patients (10,282 in the clinically matched subset) | 125 Hz | ECG, PPG, arterial BP | ICU population and care-context bias [ 65 ] |
| VitalDB | Operating room | 6,388 surgical patients | Up to 500 Hz | Multiple vital signs and waveforms | Anesthesia and OR-specific physiology [ 66 ] |
| PulseDB | Curated benchmark from MIMIC-III/VitalDB | 5,361 subjects (5,245,454 10-s segments) | 125 Hz | PPG, ECG, arterial BP labels | Inherits ICU/OR setting limitations [ 17 ] |
| PPG-BP | Seated, clinical room | 219 subjects aged 20–89 (657 records) | 1 kHz | Fingertip PPG (2.1-s segments), cuff BP | Very short single-session recordings [ 67 ] |
| Aurora-BP | Laboratory and 24-h ambulatory | More than 1,000 participants | Device-dependent | Wrist PPG, ECG, tonometry, accelerometry, ambulatory cuff | Intermittent cuff reference; single device family [ 68 ] |
| Other ambulatory wearable datasets | Daily life | Varies by study; often small | Device-dependent, commonly 25–100 Hz | PPG, accelerometry, cuff references | Realistic deployment conditions but harder to collect and standardize |
| Issue | Reason | Reporting need |
|---|---|---|
| Initial calibration | Aligns model output to individual BP level | Number and type of reference readings |
| Repeated calibration | Maintains accuracy as physiology changes | Recalibration interval and trigger |
| Calibration-free design | Avoids cuff dependency | Subject-independent external validation |
| Calibration drift | Signal–BP relationship changes over time | Error versus time since calibration |
| Physiological state | Rest, stress, sleep, exercise, and posture alter signals | Calibration and use conditions |
| Bias source | How it affects cuffless BP | What should be reported | Clinical risk |
|---|---|---|---|
| Skin and tissue optics | Alters PPG signal strength and morphology | Skin tone or pigmentation-relevant descriptors when feasible | Uneven accuracy across users |
| Age and vascular stiffness | Changes pulse wave velocity and morphology | Age range and vascular disease status | Poor transfer across age groups |
| Medication and disease | Alters vascular tone, heart rate, and BP dynamics | Medication and comorbidity information | Misleading BP trends |
| Care setting | ICU/OR data differ from daily-life wearable use | Dataset source and acquisition context | Benchmark accuracy may not translate |
| Sensor site | Wrist, finger, ear, and phone PPG differ in signal quality | Sensor location and attachment method | Site-specific failure modes |
| Motion and posture | Corrupts PPG and changes hydrostatic conditions | Activity and posture during measurement | Failure during real-world use |
| Condition | Reason for inclusion |
|---|---|
| Resting seated posture | Baseline comparison with conventional measurement |
| Standing posture | Tests hydrostatic and vascular changes |
| Walking or arm movement | Tests motion robustness |
| Exercise or recovery | Tests BP increase and dynamic tracking |
| Sleep or supine rest | Tests nocturnal monitoring feasibility |
| Cold or low-perfusion state | Tests weak PPG signal conditions |
| Stage | Evidence needed | Main question | Claim supported |
|---|---|---|---|
| Retrospective benchmark | Curated waveform data with clear splits | Can the algorithm estimate BP on existing data? | Feasibility |
| Controlled validation | Standardized posture, activity, and BP-change testing | Does the device work under controlled conditions? | Technical validation |
| Ambulatory validation | Daily-life testing with realistic motion and sensor use | Does the device work outside the lab? | Wearable-use validation |
| Longitudinal validation | Repeated testing over time after calibration | Does accuracy remain stable? | Drift and recalibration evidence |
| Clinical outcome evaluation | Diagnosis, treatment, adherence, or risk-prediction studies | Does the device improve care? | Clinical utility |
| Item | Required detail |
|---|---|
| Population | Age, sex, health status, BP range |
| Sensor site | Wrist, finger, ear, phone, or other |
| Signals | PPG only or multimodal inputs |
| Reference BP | Cuff, arterial line, or other source |
| Calibration | Initial, repeated, or calibration-free |
| Split design | Subject-independent and temporal policy |
Cuffless Blood Pressure Estimation
Cuffless blood pressure estimation infers blood pressure from signals such as photoplethysmography without an inflatable cuff.
See all 17 papers